Sanofi, Stryker, Market Shares in Tissue Engineering Market| Key Players: Medtronic, Zimmer Biomet, Acelity, Integra LifeSciences

Tissue engineering market size was valued at USD 5 billion in 2015 and is anticipated to exhibit significant growth over the next seven years. Rising need to bridge the organ demand and supply gap is expected to drive industry demand.

Orthopedic applications contributed more than 50% to the tissue engineering market share in 2015, and will continue leading revenue generation, mainly due to increased number of bone implants as a result of accidents and aging population base. Considerable degree of research in the neurology space will drive segment demand.

Escalating popularity in numerous sectors such as neurology, burn treatment or wound care, and urological products is expected to fuel tissue engineering market growth over the forecast timeframe.

Get Table of Content of this Report @ https://www.gminsights.com/request-toc/upcoming/438

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
• Sanofi
• Stryker
• Medtronic
• Zimmer Biomet
• Acelity
• Integra LifeSciences
• Organogenesis Inc.
• Athersys
• RTI Surgical®
• CryoLife, Inc.
• StemCells, Inc.
• Arteriocyte (Now Isto Biologics)

North America accounted for largest share in 2015 and is likely to continue its dominance till 2023, driven by the U.S. tissue engineering market. The growth can be attributed to existence of leading industry participants across the region as well as high financial support from the government as well as private organizations for research and development.

Organs developed by this procedure exhibit high durability and efficiency. Increasing applications of this technique from surgical manipulation of tissues and prosthetics to corneal, liver, and cardiac tissue engineering is predicted to propel growth from 2016 to 2023.

Increasing organ transplantation cost accompanied by growing 3D printing prominence in medical applications for regeneration is anticipated to drive industry growth over the next seven years.

High product efficiency as well as reduced rejection ratio is expected to further accelerate the industry demand. High cost involvement and slow development along with increasing biological complexity is anticipated to restrain the tissue engineering market.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/438

Cancer, cord blood & cell banking, GI & gynecology, skin or integumentary, dental, urology, musculoskeletal, orthopedics, spine, cardiology & vascular and neurology are the key application segments. Rising number of replacement as well as reconstructive surgeries has favored industry growth. In addition, increasing accident frequency paired with surging aged population is expected to drive the need for bone implants.

Escalating dental applications are forecast to positively impact the tissue engineering market from 2016 to 2023. This can be credited to wide development scope and rapidly growing research in the field. Based on type of material used, the industry can be segregated into genetically modified, biological materials, and synthetic.

Global Market Insights Inc. is a global market research and management consulting company catering to leading corporations, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

Global Market Insights, Inc.
4 North Main Street
Selbyville, Delaware 19975 USA
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:sales@gminsights.com

This release was published on openPR.